Mayo Clinic Laboratory and Pathology Research Roundup: April 30 - Insights
This week's research roundup feature: Patients with dementia with Lewy bodies (DLB) may have Alzheimers disease (AD) pathology that can be detected by plasma biomarkers. Our objective was to evaluate plasma biomarkers of AD and their...
Mayo Clinic Laboratory and Pathology Research Roundup: April 23 - Insights
This week's research roundup feature: Only 20 percent of renal and bladder cancer patients will show a significant response to immune checkpoint inhibitor (ICI) therapy, and no test currently available accurately predicts ICI response. We...
Mayo Clinic Laboratory and Pathology Research Roundup: May 7 - Insights
This week's research roundup feature: To standardize international normalized ratio (INR) measurements and improve data integrity by enabling electronic result transmission for warfarin monitoring, two point-of-care (POC) devices were...
Mayo Clinic Laboratory and Pathology Research Roundup: January 9 - Insights
This week's research roundup feature: To describe a 41-year-old woman with a history of neonatal onset multisystem inflammatory disease, on treatment with daily subcutaneous injections of 600 mg of recombinant interleukin-1 receptor...
Mayo Clinic Laboratory and Pathology Research Roundup: February 6 - Insights
This week's research roundup feature: Powassan virus (POWV) is an emerging arthropod-borne flavivirus, transmitted by Ixodes spp. ticks, which has been associated with neuroinvasive disease and poor outcomes.
Leveraging Lessons from the Past - Insights
Sharing lessons learned from past process improvement and other projects conducted at Mayo Clinic.
Eye on Innovation features exciting advances taking place at Mayo Clinic Laboratories. This monthly series shines a spotlight on recently developed tests, and highlights how Mayo Clinic translates ideas and discoveries into testing...
Mayo Clinic Laboratory and Pathology Research Roundup: February 27 - Insights
This week's research roundup feature: Both targeted therapies and immunotherapies provide benefit in resected Stage III melanoma. We hypothesized that the combination of targeted and immunotherapy given prior to therapeutic lymph node...
Mayo Clinic Laboratory and Pathology Research Roundup: March 19 - Insights
This week's research roundup feature: The revised 4th edition of the World Health Organization (WHO4R) classification lists myelodysplastic syndromes with ring sideroblasts (MDS-RS) as a separate entity with single lineage (MDS-RS-SLD) or...
Using Data-Driven, In-Person Discussions to Support Outreach Clients - Insights
In this episode of Mayo Clinic Laboratories’ “Leveraging the Laboratory” podcast, host Jane Hermansen, outreach manager at Mayo Clinic Laboratories, speaks with outreach solutions strategists Ellen Dijkman Dulkes and Brianne Newton. They...